ArticleDrugs in context2019

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system.

Vincenzo Accurso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.